R 051543Z FEB 21
MARADMIN 059/21
MSGID/GENADMIN/CMC WASHINGTON DC MRA MP//
SUBJ/SUPPLEMENTAL MESSAGE TO MARADMIN 333-20 TO INCORPORATE FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 14) DIRECTIONS//
REF/A/MSGID/MEMO/SECDEF/20APR20//
REF/B/MSGID/MARADMIN/CMC WASHINGTON DC PPO/R212257APR20//
REF/C/MSGID/MEMO/USD(PR)/11MAR20//
REF/D/MSGID/MARADMIN/CMC WASHINGTON DC MRA MP/R262107ZAPR20//
REF/E/MSGID/MEMO/SECDEF/22MAY20//
REF/F/MSGID/MARADMIN/CMC WASHINGTON DC MRA MM/R052305ZJUN20//
REF/G/MSGID/MARADMIN/CMC WASHINGTON DC MRA MM/R221935ZOCT20//
REF/H/MSGID/MEMO/SECDEF/29JUN20//
REF/I/MSGID/MEMO/ASN(MRA)/30JUN20//
REF/J/MSGID/MARADMIN/CMC WASHINGTON DC MRA MP/R011115ZJUL20//
REF/K/MSGID/MEMO/USD(PR)/06AUG20//
REF/L/MSGID/MARADMIN/CMC WASHINGTON DC MRA MM/R242030ZAUG20//
REF/M/MSGID/MEMO/USD(PR)/29DEC20//
REF/N/MSGID/JOINT TRAVEL REGULATIONS//
REF/O/MSGID/MARADMIN/CMC WASHINGTON DC PPO/R172355ZJUN20//
REF/P/MSGID/MARADMIN/CMC WASHINGTON DC DMCS/R062151ZAPR20//
REF/Q/MSGID/MARADMIN/CMC WASHINGTON DC HS/R160145ZAPR20//
REF/R/MSGID/MARADMIN/CMC WASHINGTON DC PPO/R182015ZSEP20//
REF/S/MSGID/DOC/MCO 1050.3J/19MAY09//
REF/T/MSGID/DOC/PAA 04-20/07MAY20//
REF/U/MSGIG/DOC/PAA 07-20/12AUG20//
REF/V/MSGID/MARADMIN/CMC WASHINGTON DC MRA RA/R231425ZJUN20//
REF/W/MSGID/DOC/MCO 1001R.1L/15MAR18//
REF/X/MSGID/MEMO/USD(PR)/13APR20//
REF/Y/MSGID/MEMO/ASN(MRA)/06JAN21//
REF/Z/MSGID/MEMO/USD(PR)/24AUG20//
REF/AA/MSGID/MEMO/USD(PR)/11JUN20//
REF/AB/MSGID/MEMO/DHA/02JUL20//
REF/AC/MSGID/DOC/DODI 6025.23/16SEP11//
REF/AD/MSGID/GENADMIN/USTRANSCOM TCJ3/11JAN21//
REF/AE/MSGID/DOC/CDC ORDER/12JAN21//
REF/AF/MSGID/GENADMIN/USTRANSCOM TCJ3/23JAN21//
REF/AG/MSGID/GENADMIN/HQAMC A4T/26JAN21//
NARR/REF A IS OSD MEMORANDUM, MODIFICATION AND REISSUANCE OF DOD RESPONSE TO CORONAVIRUS DISEASE 2019 – TRAVEL RESTRICTIONS. REF B IS MARADMIN 254/20, UPDATE 7: U.S. MARINE CORPS DISEASE CONTAINMENT PREPAREDNESS PLANNING GUIDANCE FOR 2019 NOVEL CORONAVIRUS (COVID-19): MODIFICATION AND REISSUANCE OF DOD RESPONSE TO CORONAVIRUS DISEASE 2019-TRAVEL RESTRICTIONS. REF C IS USD(PR) MEMORANDUM, FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 4) – DEPARTMENT OF DEFENSE GUIDANCE FOR PERSONNEL TRAVELING DURING THE NOVEL CORONAVIRUS OUTBREAK. REF D IS MARADMIN 264/20, UPDATE 1: COVID-19 SUPPLEMENTAL PERSONNEL GUIDANCE. REF E IS OSD MEMORANDUM, TRANSITION TO CONDITIONS-BASED PHASED APPROACH TO CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS. REF F IS MARADMIN 333/20, TRANSITION TO CONDITIONS-BASED PHASED APPROACH TO CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS UPDATE. REF G IS MARADMIN 636/20, UPDATE TO MARADMIN 333-20 TO INCORPORATE CHANGE TO DELEGATION OF WAIVER APPROVAL AUTHORITY FOR CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS. REF H IS OSD MEMORANDUM, EXEMPTION OF AUTHORIZED LEAVE FOR DEPARTMENT OF DEFENSE SERVICE MEMBERS FROM CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS. REF I IS ASN(MRA) MEMORANDUM, DEPARTMENT OF THE NAVY EXEMPTION OF AUTHORIZED LEAVE FOR SERVICE MEMBERS FROM CORONAVIRUS DISEASE 2019 PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS. REF J IS MARADMIN 377/20, DOD POLICY CHANGE, COVID-19 MILITARY PERSONNEL MOVEMENT AND TRAVEL RESTRICTIONS – LEAVE AND LIBERTY. REF K IS USD(PR) MEMORANDUM, FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 12) – DEPARTMENT OF DEFENSE GUIDANCE FOR PERSONNEL TRAVELING DURING THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF L IS MARADMIN 488/20, SUPPLEMENTAL MESSAGE TO MARADMIN 333-20 TO INCORPORATE FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 12) DIRECTIONS. REF M IS USD(PR) MEMORANDUM, FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 14) – DEPARTMENT OF DEFENSE GUIDANCE FOR PERSONNEL TRAVELING DURING THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF N IS THE JOINT TRAVEL REGULATIONS. REF O IS MARADMIN 353/20, U.S. MARINE CORPS GUIDANCE FOR DEPLOYMENT AND REDEPLOYMENT OF INDIVIDUALS AND UNITS, SURVEILLANCE AND SCREENING AND TESTING, AS WELL AS LABORATORY DIAGNOSTIC TESTING DURING THE NOVEL CORONAVIRUS DISEASE 2019 PANDEMIC. REF P IS MARADMIN 218/20, UPDATE 5: U.S. MARINE CORPS DISEASE CONTAINMENT PREPAREDNESS PLANNING GUIDANCE FOR 2019 NOVEL CORONAVIRUS (COVID-19): MARINE CORPS GUIDANCE ON THE USE OF CLOTH FACE COVERINGS. REF Q IS MARADMIN 236/20, UPDATE 6: U.S. MARINE CORPS DISEASE CONTAINMENT PREPAREDNESS PLANNING GUIDANCE FOR 2019 NOVEL CORONAVIRUS (COVID-19): PROTECTING PERSONNEL IN WORKPLACES. REF R IS MARADMIN 537/20, SUPPLEMENTAL U.S. MARINE CORPS GUIDANCE FOR DEPLOYMENT AND REDEPLOYMENT OF INDIVIDUALS AND UNITS, SURVEILLANCE AND SCREENING AND TESTING, AS WELL AS LABORATORY DIAGNOSTIC TESTING DURING THE NOVEL CORONAVIRUS DISEASE 2019 PANDEMIC. REF S IS MCO 1050.3J, REGULATIONS FOR LEAVE, LIBERTY, AND ADMINISTRATIVE ABSENCE. REF T IS PAA 04-20, SUPPLEMENTAL GUIDANCE IN THE REPORTING OF COVID-19 PERSONNEL STATUS. REF U IS PAA 07-20, SUPPLEMENTAL GUIDANCE IN THE REPORTING OF COVID-19 PERSONNEL STATUS. REF V IS MARADMIN 365/20, CLARIFYING GUIDANCE TO RESERVE COMPONENT PERFORMANCE OF INACTIVE DUTY TRAINING, ANNUAL TRAINING AND INDIVIDUAL READY RESERVE MUSTER IN PERSISTENT PANDEMIC ENVIRONMENT. REF W IS MCO 1001R.1L, MARINE CORPS RESERVE ADMINISTRATIVE MANAGEMENT MANUAL (SHORT TITLE: MCRAMM). REF X IS USD(PR) MEMORANDUM, FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 8) – DEPARTMENT OF DEFENSE GUIDANCE FOR PROTECTING PERSONNEL IN WORKPLACES DURING THE RESPONSE TO THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF Y IS ASN(MRA) MEMORANDUM, DEPARTMENT OF THE NAVY GUIDANCE FOR PERSONNEL TRAVELING DURING THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF Z IS USD(PR) MEMORANDUM, FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 13) – DEPARTMENT OF DEFENSE GUIDANCE FOR CORONAVIRUS 2019 CLINICAL DIAGNOSTIC TESTING SERVICES. REF AA IS USD(PR) MEMORANDUM, FORCE HEALTH PROTECTION GUIDANCE (SUPPLEMENT 11) – DEPARTMENT OF DEFENSE GUIDANCE FOR CORONAVIRUS DISEASE 2019 SURVEILLANCE AND SCREENING WITH TESTING. REF AB IS DIRECTOR, DEFENSE HEALTH AGENCY, MEMORANDUM, SUPPLEMENTAL HEALTH CARE PROGRAM BLANKET WAIVER FOR CORONAVIRUS 2019 (COVID-19) TESTING FOR ASYMPTOMATIC TIER 1-4 ACTIVE DUTY SERVICE MEMBERS. REF AC IS DODI 6025.23, HEALTH CARE ELIGIBILITY UNDER THE SECRETARIAL DESIGNEE (SECDES) PROGRAM AND RELATED SPECIAL AUTHORITIES. REF AD IS USTRANSCOM TCJ3 GENADMIN TO THE JOINT FORCE UPDATING COVID-19 TRAVEL REQUIREMENTS IN RESPONSE TO FORCE HEALTH PROTECTION SUPPLEMENT 14. REF AE IS CENTERS FOR DISEASE CONTROL AND PREVENTION DEPARTMENT OF HEALTH AND HUMAN SERVICES, REQUIREMENT FOR NEGATIVE PRE-DEPARTURE COVID-19 TEST RESULT OR DOCUMENTATION OF RECOVERY FROM COVID-19 FOR ALL AIRLINE OR OTHER AIRCRAFT PASSENGERS ARRIVING INTO THE UNITED STATES FROM ANY FOREIGN COUNTRY. REF AF IS USTRANSCOM AMENDED GUIDANCE TO THE JOINT FORCE UPDATING COVID-19 TRAVEL REQUIREMENTS FOR TRAVELERS MOVING FROM OCONUS TO CONUS DESTINATIONS IN RESPONSE TO FORCE HEALTH PROTECTION SUPPLEMENT 14. REF AG IS HQ AMC MESSAGE, PASSENGER DATA COLLECTION, SCREENING AND TRAVEL ELIGIBILITY RELATED TO CORONAVIRUS.//
POC/SEE PARAGRAPH 13//
GENTEXT/REMARKS/1.  Background
1.a.  Pursuant to ref (a), ref (b) implemented travel restriction guidance, to include pre- and post-travel screening and restriction of movement (ROM) procedures as provided in ref (c).
1.b.  Ref (d) supplemented ref (b) regarding assignments, leave accrual, entitlements, allowances, special pays, telework, and Reserve Component (RC) specific guidance.
1.c.  Ref (e) cancelled ref (a).  Accordingly, refs (f) and (g) modified and supplemented travel restrictions guidance.
1.d.  Pursuant to refs (h) and (i), ref (j) modified travel restriction guidance specific to non-official leave, liberty, and administrative absence outside of the local area and/or liberty limits.
1.e.  Ref (k) replaced ref (c), and ref (l) modified and supplemented pre- and post-travel guidance for purposes of force health protection (FHP), along with requirements for travel-associated ROM.
1.f.  Subsequent to ref (m), refs (ad) - (ag) provided USTRANSCOM guidance specific to testing prior to international air travel.
2.  Purpose.  Pursuant to refs (m) and (y), this MARADMIN supplements guidance in refs (f) and (g), and replaces refs (j) and (l) specific to pre- and post-travel guidance for Marines, Department of Defense (DoD) family members, DoD civilian employees, and DoD contractor personnel traveling for purposes other than deployment.
3.  Terminology
3.a.  All definitions for travel-related terms are found in ref (n).
3.b.  For purposes of this guidance, the term United States means the 50 States and the District of Columbia.
3.c.  COVID-related terms and definitions are provided in refs (o), (q), and (x).
4.  General Guidance
4.a.  Ref (m) is based primarily on current United States Centers for Disease Control and Prevention (CDC) travel guidance at the website, www.cdc.gov/coronavirus/2019-ncov/travelers.  Nothing in this MARADMIN waives the DoD requirement to adhere to CDC guidance to the greatest extent practicable.
4.b.  The first General Officer (GO) or SES in a member's chain of command may implement more restrictive guidance and additional FHP measures based on mission requirements and local risk assessments, in consultation with their medical staffs and public health authorities.  See para 6 for risk assessments.
4.c.  The first GO/SES in a member's chain of command may choose to exempt assigned aircrew and aircraft maintenance recovery team members on commercial, military contracted, and organic military aircraft from this guidance, to the extent permissible, consistent with applicable legal requirements.  See para 6 for risk assessments.
4.d.  DC PPO has published COVID-19 testing guidelines in refs (o) and (r).  For DoD testing guidelines, refer to refs (z), (aa), and (ab).  Additional testing information is provided in paragraph 7.
4.e.  Additional guidance specific to deployment and redeployment of individuals and units is provided in refs (o) and (r).
4.f.  In addition to personal health protective measures recommended by the CDC that have been implemented (refs (p), (q), and (x)), strict adherence to ROM guidelines is effective in limiting coronavirus disease 2019 (COVID-19) transmission.
4.g.  Refs (q) and (x) provide guidance regarding the protection of personnel from disease transmission in workplaces, including returning to work.  Any applicable requirements in refs (q) and (x) must be met prior to personnel returning to a DoD workplace.
4.h.  Patients and their attendants in the en-route care system are exempt from ROM requirements until they arrive at their final treatment destination; medical care will not be delayed due to ROM requirements.
4.i.  Conditions to resume unrestricted travel are included in refs (b), (e), (f), and (g).  Prior to travel, Marines should consult the COVID-19 Travel Restrictions Installation Status Update, available at www.defense.gov/explore/spotlight/coronavirus.
4.j.  All actions will comply with applicable labor obligations to the extent such obligations do not conflict with the Marine Corps’ ability to conduct operations during this emergency.
4.k.  Per refs (d) and (u), a COVID-19 Manpower Tracking Application enables commanders and supporting staff to report the personnel status of Marines, Sailors, civilian employees, contractors, dependents, and other Service personnel impacted by COVID-19.  To ensure the accurate categorization of personnel, commanders and supporting staff shall review these publications and, if necessary, request assistance through the DC MRA Secretariat point of contact (POC) listed in this MARADMIN.
5.  Steps To Be Taken During ROM.  During any required or recommended ROM period, individuals will to the fullest extent practicable:
5.a.  Restrict movement to their residence or other appropriate domicile as much as possible.
5.b.  Limit close contact (i.e., within 6 feet) with others, including family members or roommates; adhere to strict mask wearing and hand washing practices; avoid crowds; avoid the use of public transportation; and avoid close interaction with pets or other animals.  Adhere to strict FHP measures for 14 days post-travel even if the ROM period is less than 14 days.
5.c.  Telework when practicable per direction of commander and/or supervisor, and in accordance with ref (d).
5.d.  In coordination with their commander and/or supervisor, and depending on their specific circumstances and specific purposes, generally consider their ROM location as their official duty location.  Specific circumstances include but may not be limited to whether the individual is executing ROM as a direct result of executing official travel, whether the ROM is executed at or away from the individual’s primary duty location, etc.  Specific purposes include whether the individual is authorized non-official or administrative absence and is authorized any allowances while executing ROM, as discussed in greater detail in other paragraphs of this MARADMIN.
5.e.  Self-monitor for feeling feverish or actual fever (greater than or equal to 100.4 degrees F) by taking their temperature twice a day; and self-monitor for cough, difficulty breathing, or other COVID-19 signs and symptoms as described by the CDC at www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.  If signs or symptoms consistent with COVID-19 develop during the 14-day self-monitoring period, individuals will self-isolate, limit contact with others, and seek advice by telephone or other authorized communication modalities from an appropriate healthcare provider to determine whether medical evaluation and testing for COVID-19 is needed; and return to work only on the direction of an appropriate healthcare provider.
5.f.  For Marines, notify their chain of command or supervisor if they or persons in their household develop signs or symptoms with COVID-19.  Such health information will be protected in accordance with applicable law and policy.
5.g.  DoD civilian employees should notify supervisors if they or persons in their household developed signs or symptoms consistent with COVID-19.  Such health information will only be used for FHP purposes and will be protected in accordance with applicable laws and policy.
5.h.  If ROM is conducted prior to travel, travel to and from an Aerial Port of Debarkation/Embarkation (APOD/APOE) following ROM completion will, to the maximum extent possible, be conducted in a manner that minimizes the risk of personnel being exposed to or contracting the virus that causes COVID-19 during travel.
5.i.  For personnel whose presence is required in the workplace, consider whether and when to return to work during the ROM period in accordance with refs (q) and (x).
5.j.  Post-arrival ROM may not be required by the destination health authority (e.g., the host nation (HN) or State or local jurisdiction) if travelers comply with the destination COVID-19 testing requirements.  Travelers should check with their chain of command, GCC, State and local public health authorities, and military installations for current information.
6.  Determining Whether to Travel.  It is important for the appropriate leader, supervisor and medical personnel to complete a risk assessment for each traveler before travel, as set forth below, which includes an assessment of the health status and itinerary for all travelers.
6.a.  Requirement by Traveler Type
6.a.1.  For Marines, a risk assessment is required before all travel.
6.a.2.  For DoD family members, reimbursement for official travel may only occur once the Marine certifies, to the best of his or her knowledge, that family members have completed a risk assessment.  DoD family members are strongly encouraged to complete a risk assessment before unofficial travel as well.
6.a.2.a.  Prior to family members traveling on official orders, the Marine must attest that all family members traveling have adhered to the same requirements as set forth for Marines, including a risk assessment and ROM as applicable.  Failure to do so may prevent reimbursement of travel expenses for family.
6.a.2.b.  Commanders will ensure the attestation for Marines and/or dependents is completed within 14 days of travel.  A sample attestation memo can be found on the DC MRA portal, www.manpower.usmc.mil/webcenter/portal/Secretariat/.
6.a.2.c.  Commands will ensure Marines sign the attestation, provide the local Installation Personnel Administration Center (IPAC) a copy to file with the Marine’s orders, and ensure the Marine retains a copy of the attestation in order to facilitate reimbursement of travel expenses at the new Permanent Duty Station (PDS).
6.a.3.  For DoD civilian employees, a risk assessment is required before official travel.  DoD civilian employees are strongly encouraged to complete a risk assessment before unofficial travel as well.
6.a.4.  For DoD contractor personnel, DoD contracting officers will ensure that all contracts that include performance requiring official travel outside the United States require DoD contractor personnel to complete a risk assessment.  DoD contractor personnel are strongly encouraged to complete a risk assessment before unofficial travel as well.
6.b.  Risk Assessment.  In all cases, Marines, DoD family members, DoD civilian employees, and DoD contractor personnel should not travel if they have tested positive for COVID-19 and have not yet met the criteria for discontinuing isolation, are symptomatic, or are pending COVID-19 test results.  Travel should also be delayed if, in the past 14 days, they have been in close contact, as defined by CDC, with someone who has tested positive and/or been symptomatic of COVID-19.  Prior to travel, all travelers should be educated by their leaders and/or supervisors on how to self-monitor and what actions to take if one develops COVID-19 symptoms or contracts COVID-19.  The risk assessment of the health status of the traveler will include, at a minimum:
6.b.1.  Whether the individual has exhibited any signs or symptoms of COVID-19 within the previous 14 days.
6.b.2.  Whether the individual has had contact with anyone having, or known to have exhibited, signs or symptoms of COVID-19, or who has tested positive for COVID-19 within the previous 14 days.
6.b.3.  Whether the individual has traveled to a country, a State, territory, or county with high or increasing COVID-19 transmission within the previous 14 days, or is planning to travel to such a location.
6.b.4.  Whether the individual is at increased risk of severe illness of COVID-19.
6.b.5.  Whether the individual is familiar with how to self-monitor and what actions to take if he or she develops COVID-19 symptoms or contracts COVID-19.
7.  Testing Guidance.  Per ref (m), pre-travel and ROM-associated COVID-19 testing is authorized for official international air travel at military medical treatment facilities on a non-reimbursable basis in accordance with ref (ac) for DoD civilian employees and members of the Selected Reserve, not otherwise eligible to receive care.
7.a.  Ref (m) defines a viral test, and directs that all testing will be conducted in accordance with applicable U.S. Food and Drug Administration (FDA) and DoD regulations and guidelines.
7.b.  All personnel conducting official international air travel will be tested with a viral test one to three days before departure via commercial or military airlift and maintain proof of the negative test during travel.  If the destination location requires a specific test or test timing, personnel must follow the destination location requirement instead.  Testing is authorized on presentation of electronic or paper copy of orders at military treatment facilities in accordance with refs (m) and (ac).  Active Duty Service members are authorized to receive pre-travel testing in accordance with ref (ab) and applicable Military Department Guidance.
7.b.1.  Every effort should be made to complete the testing; however, pre-travel testing may be waived if testing is not available or cannot be conducted in a timely manner with regard to scheduled travel.  In these cases, approval authority for waiving pre-travel testing is delegated to the first GO/SES in the traveler's chain of command.  The approving official must consider HN pre-travel testing requirements and in the case of Service member travel via USTRANSCOM, any USTRANSCOM requirements for pre-travel testing.  The approval authority must coordinate with the receiving command if applicable.
7.b.1.a.  USTRANSCOM and AMC requirements are promulgated in refs (ad), (af), and (ag).  These requirements are extensive, and must be read in their entirety; failure to comply with these requirements may result in denial of boarding.  Further, passengers not meeting destination country and GCC requirements prior to departure may have their boarding denied by TRANSCOM.
7.b.1.b.  For waiving authorities, refs (ad), (af), and (ag) list the information that must be included in waiver documentation, and provided to the individual traveler.
7.b.1.c.  Per refs (ad), (af), and (ag), the COVID-19 vaccine does not exempt a traveler from complying with the pre-travel testing requirement.
7.b.1.d.  The waiving authority must coordinate with the receiving command if applicable.
7.b.1.e.  Pre-travel testing waivers must be provided to the member in writing by the approving official.
7.c.  All personnel conducting unofficial international air travel are recommended to be tested with a viral test one to three days before departure via commercial or military airlift and maintain proof of the negative test during travel.
7.d.  For travel via military airlift (contracted or organic), APOE health screening is mandatory.  Travelers who have a medical issue identified during screening, or who refuse to be tested or screened at the APOE, may be denied travel.
7.e.  See paragraph 6 regarding risk assessments.
8.  Travel Guidance.  In addition to completion of ROM, additional requirements may be necessary when traveling to or from locations outside the U.S.  The requirements or recommendations are listed below by travel destination (within or outside the United States), CDC Travel Health Notice (THN) Level, type of travel (official or unofficial), and person traveling (Marine, DoD family member, DoD civilian employee, or DoD contractor personnel).  The waiver authority available to the Secretaries of the Military Departments, Heads of OSD Components, and Commanders of the GCCs for official travel is specified below.  Travel between and through foreign countries contained wholly within a single GCC area of responsibility, and between GCCs, is not subject to ref (m) and will be managed by each GCC or GCCs as appropriate.  Per ref (y), for travel from the United States or U.S. territory to another country, the Marine Corps must follow all requirements imposed by the GCC with responsibility over the destination geographic area, all applicable HN procedures, and all requirements of the Electronic Foreign Clearance Guide (EFCG).
8.a.  Travel from the United States or United States Territory to Another Country
8.a.1.  Official Travel
8.a.1.a.  Marines
8.a.1.a.1.  Will conduct a travel-associated ROM as follows:
8.a.1.a.1.a.  Upon arrival at the foreign country destination:
8.a.1.a.1.a.1.  The Marine Corps and Marines must comply with applicable HN requirements.
8.a.1.a.1.a.2.  ROM for 14 days without testing; or if after an appropriate risk assessment, the first GO/SES in a traveler's chain of command or supervision may decrease to a ROM of 10 days without testing; or ROM of seven days with a test within 48 hours of the end of the seven-day ROM, and end ROM at seven days if the test is negative.
8.a.1.a.1.a.3.  For any travel-associated ROM, follow the procedures specified in paragraph 5 (i.e., Steps to be Taken During ROM).
8.a.1.a.1.b.  If the GCC or HN requires a pre-arrival ROM, the Marine will follow the 14-day, 10-day, or seven-day ROM procedures described above at an appropriate domicile prior to departure and complete pre-travel testing within one to three days.
8.a.1.a.1.c.  Only one ROM is required, either before travel or after arrival, unless otherwise required by applicable HN procedures.
8.a.1.a.2.  Must follow all requirements imposed by the GCC with responsibility over the destination geographic area, all applicable HN requirements and procedures, and all requirements of the EFCG.  Per ref (m), each Service maintains the authority to determine how necessary ROM and movement, including the mode of transportation and final destinations, are executed.  GCCs remain responsible for adherence to applicable HN COVID-19 policies and requirements.  Each Service must comply with existing and otherwise applicable HN requirements.
8.a.1.b.  DoD Family Members.  Prior to family members engaging in official travel, Marines must attest that, to the best of their knowledge, their family members have followed the same requirements set forth for Marines in this guidance.  Failure to do so may result in delay or cancellation of previously authorized travel.  This attestation requirement will be incorporated into travel orders issued to Marines.  See paragraph 6.a.2.
8.a.1.c.  DoD Civilian Employees
8.a.1.c.1.  Will conduct a travel-associated ROM as described above for Marines.
8.a.1.c.2.  Must follow all requirements imposed by the GCC with responsibility over the destination geographic area, all applicable HN procedures, and all requirements of the EFCG.  Per ref (m), the Military Departments maintain the authority to determine how necessary ROM and movement, including the mode of transportation and final destinations, are executed.  GCCs remain responsible for adherence to applicable HN COVID-19 policies and requirements.  Military Departments must comply with existing and otherwise applicable HN requirements.
8.a.1.d.  DoD Contractor Personnel.  DoD contracting officers will ensure that all contracts that include performance outside the United States require DoD contractor personnel to comply with the country entry requirements of the respective GCC (which may include screening, ROM, and testing), as reflected in the EFCG, and all applicable HN procedures.  The GCC may waive such additional requirements, consistent with existing authorities.
8.a.2.  Unofficial Travel
8.a.2.a.  Marines will comply with current Marine Corps guidance and/or GCC and HN procedures for the areas to which, and through which, they are traveling.
8.a.2.b.  DoD family members, DoD civilian employees, and DoD contractor personnel should comply with the guidance and/or applicable HN procedures for the areas to which, and through which, they are traveling, and are strongly recommended to follow the FHP guidance provided within this document and any other DoD Component-specific guidance.
8.b.  Travel From or Through a Foreign Country or U.S. Territory to the United States
8.b.1.  Official Travel
8.b.1.a.  Marines
8.b.1.a.1.  Will conduct a pre-travel screening prior to departure.  If indicated by the screening, delay travel and consult a healthcare provider for clearance to travel.
8.b.1.a.2.  Will conduct a risk assessment (see paragraph 6.b.) upon arrival in the United States.  Those who become ill or have had close contact with a person known to have contracted COVID-19 during travel must self-isolate (if ill) or quarantine (if exposed but not ill) as defined in refs (o), (q), and (x), and notify their chain of command or supervisor.
8.b.1.a.3.  If traveling from, or having traveled through, a foreign country or U.S. territory designated as CDC THN Level 4, 3, or 2, the Marine will, upon arrival at his or her destination domicile:
8.b.1.a.3.a.  ROM for 14 days without testing; or if after an appropriate risk assessment, the first GO/SES in a traveler's chain of command or supervision may decrease to a ROM of 10 days without testing; or ROM of seven days with a test within 48 hours of the end of the seven-day ROM, and end ROM at seven days if the test is negative.
8.b.1.a.3.a.1.  Reservists returning from mobilization/deployment may utilize R-ILOC to meet this requirement.
8.b.1.a.3.b.  For any travel-associated ROM, follow the procedures specified in paragraph 5 (i.e., Steps to be Taken During ROM).
8.b.1.a.3.c.  The ROM requirements may be waived by SECNAV on a case-by-case basis with appropriate risk assessment and mitigation measures.
8.b.1.a.3.d.  Comply with all installation, CDC, State, and local government guidance.
8.b.1.a.3.e.  Personnel whose presence is required in the workplace may return to work during the ROM period in accordance with refs (q) and (x).
8.b.1.a.4.  If traveling from a foreign country or U.S. territory designated as CDC THN Level 1, and if the Marine has not otherwise entered a CDC THN Level 4, 3, or 2 foreign country or U.S. territory, the Marine will, upon arrival at his or her destination domicile:
8.b.1.a.4.a.  Self-monitor for 14 days as described above.
8.b.1.a.4.b.  Notify his or her chain of command or supervisor if he or she develops a fever or symptoms consistent with COVID-19.
8.b.1.a.4.c.  Comply with all military installation, CDC, State and local government guidance.
8.b.1.b.  DoD family members are strongly recommended to follow the FHP guidance that is provided in this MARADMIN for Marines during all travel.
8.b.1.c.  DoD civilian employees and DoD contractor personnel are strongly recommended to follow the FHP guidance that is provided in this MARADMIN for Marines during all travel.  Any applicable requirements in refs (q) and (x) must be met prior to returning to a DoD workplace.
8.b.2.  Unofficial Travel
8.b.2.a.  Marines
8.b.2.a.1.  Will comply with current Marine Corps or DoD Component-specific guidance and/or procedures of the GCC and HN applicable to the countries to which, and through which, they are traveling.
8.b.2.a.2.  Who become ill or have had close contact with a person known to have contracted COVID-19 during travel must self-isolate (if COVID-19 positive and/or symptomatic) or quarantine (if exposed but not COVID-19 positive) as defined in refs (o), (q), and (x), and notify their chain of command or supervisor.
8.b.2.a.3.  If traveling from, or having traveled through, a foreign country or U.S. territory designated as CDC THN Level 4, 3, or 2, will follow the pre-travel screening, risk assessment and ROM procedures outlined above for a CDC THN Level 4, 3, or 2 foreign country.
8.b.2.a.4.  If traveling from a foreign country or U.S. territory designated as CDC THN Level 1, and has not otherwise entered a CDC THN Level 4, 3, or 2 foreign country, will follow the procedures outlined above for a CDC THN Level 1 foreign country.
8.b.2.b.  DoD family members are strongly recommended to follow the FHP guidance provided in this MARADMIN for Marines.
8.b.2.c.  DoD civilian employees and DoD contractor personnel are strongly recommended to follow the FHP guidance provided within this MARADMIN for Marines.  Any applicable requirements in refs (q) and (x) must be met prior to returning to a DoD workplace.
8.c.  Travel within the United States
8.c.1.  Official Travel
8.c.1.a.  Marines
8.c.1.a.1.  May conduct unrestricted travel between installations that meet the criteria provided in refs (b), (e), (f), and (g).  Prior to travel, Marines should consult the COVID-19 Travel Restrictions Installation Status Update, available at the website www.defense.gov/explore/spotlight/coronavirus.
8.c.1.a.2.  Will comply with military installation, State, and local government travel restrictions.
8.c.1.a.3.  Will comply with current CDC guidance as well as Marine Corps or DoD Component-specific guidance and/or procedures for screening, ROM, and testing.  Testing is authorized per ref (ab).
8.c.1.b.  DoD family members are strongly recommended to follow the FHP guidance provided within this MARADMIN for Marines during all travel.
8.c.1.c.  DoD civilian employees and DoD contractor personnel are strongly recommended to follow the guidance provided within this MARADMIN for Marines during all travel.  Any applicable requirements in refs (q) and (x) must be met prior to returning to a DoD workplace.
8.c.2.  Unofficial Travel
8.c.2.a.  Marines
8.c.2.a.1.  Should consult the COVID-19 Travel Restrictions Installation Status Update, available at the website www.defense.gov/explore/spotlight/coronavirus/, prior to travel.
8.c.2.a.2.  Will comply with military installation, State, and local government travel restrictions.
8.c.2.a.3.  Will comply with CDC guidance as well as Marine Corps or DoD Component-specific guidance and/or procedures for screening, ROM, and testing.
8.c.2.b.  DoD family members are strongly recommended to follow the FHP guidance within this MARADMIN for Marines during all travel.
8.c.2.c.  DoD civilian employees and DoD contractor personnel are strongly recommended to follow the guidance provided within this MARADMIN for Marines during all travel.  Any applicable requirements in refs (q) and (x) must be met prior to returning to a DoD workplace.
9.  Allowances.  The allowances in paragraph 5.a.2., ref (f), apply only to circumstances wherein Marines and dependents are required to ROM incident to executing official travel.  These allowances are separate and distinct from the allowances (i.e., HDP-ROM, BAS II) authorized for Marines incident to being required to ROM at their PDS, as addressed in paragraph 6.c., ref (f).
10.  Leave and Liberty Update: Non-official Leave, Liberty, and Administrative Absence.  Per refs (h) and (i), ref (e) was modified to allow approval of leave outside the local area at a level no lower than the unit commander or equivalent.  Similarly, Marine Corps guidance is that non-official leave, liberty, and administrative absence will be approved at a level no lower than the unit commander or equivalent, who is authorized to approve leave in accordance with ref (s), without delegation.
10.a.  Commander is described in chapter 1, paragraph 3 of ref (s).
10.b.  Per refs (h) and (i), this authority resides with the Marine's commander or equivalent.
10.c.  This authority does not waive the requirements to adhere to the guidance in this MARADMIN, current and subsequent FHP guidance, and CDC guidance.
10.d.  Commanders will establish pre- and post-travel screening and reception procedures for all authorized travelers.  These procedures will include guidance for establishing a means of communication with all Marines throughout the pre- and post-travel screening and reception process as well as information regarding prescribed actions for their particular circumstances, including ROM or isolation if required.
10.e.  Travel restriction and waiver guidance contained in refs (b), (e), (f), and (g) still applies, including in cases of leave taken in conjunction with an official travel itinerary (e.g., leave taken in conjunction with Government-funded travel, Permanent Change of Station travel, Temporary Duty travel).
10.f.  In the event a Marine returns from leave, liberty, or administrative absence and is subsequently diagnosed positive for COVID-19 by a competent medical authority, or ordered into a ROM status, commands are obligated to report this information as announced in refs (d), (t), and (u).
10.g.  Marines will comply with all DoD, Federal, State and local government restrictions, along with command guidance, while on leave, liberty, or administrative absence.
10.h.  Ref (d) provides guidance regarding convalescent leave, alternate places of duty, and excess leave accrual.  Commanders will continue to encourage Marines to use their leave, in a manner consistent the COVID-19-related policies and guidance, during the year it is earned.
11.  Additional Guidance to Assist Commanders with Travel Decisions
11.a.  The Department of Defense Joint Travel Regulations are available at www.defensetravel.dod.mil/site/travelreg.cfm.
11.b.  DoD COVID-19 Response and Operations Platform provides travel scenarios and COVID-19 installation status and information to scope, plan, and approve travel by providing awareness of HPCON levels and COVID-19 hotspots:  covid-status.data.mil/#/.
11.c.  The Defense Health Agency’s Armed Forces Health Surveillance Division (AFHSD), provides a Trajectory of Civilian COVID-19 Cases by County for the U.S. at the AFHSB COVID-19 Dashboard at:
11.c.1.  go.intelink.gov/25BWvsS.
11.c.2.  covid-status.data.mil/#/.
11.d.  Travel Restriction Installation Status Updates at www.defense.gov/Explore/Spotlight/Coronavirus/.
11.e.  CDC travel guidance updates are located at:
11.e.1.  www.cdc.gov/coronavirus/2019-ncov/php/risk-assessment.html.
11.e.2.  www.cdc.gov/coronavirus/2019-ncov/travelers/map-and-travel-notices.html.
11.e.3.  www.cdc.gov/coronavirus/2019-ncov/travelers/after-travel-precautions.html.
11.e.4.  www.cdc.gov/coronavirus/2019-ncov/travelers/faqs.html#Domestic-Travel.
11.e.5.  www.cdc.gov/coronavirus/2019-ncov/travelers/travel-during-covid19.html.
11.e.6.  www.cdc.gov/coronavirus/2019-ncov/travelers/testing-air-travel.html.
11.e.7.  www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-options-to-reduce-quarantine.html.
11.e.8.  www.cdc.gov/coronavirus/2019-ncov/travelers/faqs.html.
11.e.9.  www.cdc.gov/coronavirus/2019-ncov/travelers/travel-planner/index.html.
11.f.  COVID-19 Signs and Symptoms are available at www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
11.g.  CDC definition of close contact is available at www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/appendix.html#contact.
12.  Additional Guidance for RC Marines
12.a.  SECNAV may issue any additional procedural guidance as appropriate for RC personnel.
12.b.  RC Marines on official travel will complete any required health and ROM measures, including home-based quarantine or self-isolation if required, prior to the end of the official duty period.
12.c.  RC Marines shall continue to comply with guidance as set forth in ref (v) as it relates to entitlements when ROM is required.
12.d.  Travel to and from Inactive Duty Training (IDT) located at a Marine’s Home Training Center (HTC) will be conducted in an unofficial travel capacity.  Marines traveling to alternate duty locations or offsite training locations, shall do so in accordance with ref (w).  Marines traveling to HTC shall still be eligible to receive IDT travel reimbursement.
12.e.  Unofficial travel, to include travel to and from IDT and personal travel not in a duty status, shall be conducted in accordance with this MARADMIN.
13.  Points of Contact (POC).  All personnel shall use their chain of command for queries and requests for information.  The following POCs should be used only after a member’s chain of command has been unable to assist.
13.a.  DC MRA, Manpower Military Personnel Policy:  mpo@usmc.mil.
13.b.  DC MRA, Active Duty Military Manpower Management:  smb.manpower.mmib1@usmc.mil.
13.c.  DC MRA, Active Reserve and Selected Reserve Marines:  rap@usmc.mil and joinar@usmc.mil.
13.d.  DC MRA, Secretariat/Manpower Information:  dc.mra.secretariat.office@usmc.mil.
13.e.  DC MRA, Civilian Employees:  michelle.delmedico@usmc.mil; frances.burt@usmc.mil.
13.f.  DC AVN:  douglas.h.howard@usmc.mil.
13.g.  DC IL:  frederick.hyden@usmc.mil; mark.a.edwards5@usmc.mil.
13.h.  DC PPO, Marine Corps COVID Cell (MCCC):  smb_hqmc_mccat@usmc.mil.
13.i.  DC PR (RFF):  paul.w.evans@usmc.mil; hqmc_P_R_RFF@usmc.mil.
13.j.  Dir HS:  stephen.a.chapman@usmc.mil.
14.  This MARADMIN applies to the Total Force.
15.  This MARADMIN has been coordinated with DC AVN, DC IL, DC PPO, DC PR, and Director HS, and approved for release by LtGen David A. Ottignon, Deputy Commandant for Manpower and Reserve Affairs.//